Reducing brain damage post-stroke

Researchers at The University of Queensland have developed a neuroprotective therapeutic to apply in the treatment of brain injury following a stroke. The agent is a peptide-based inhibitor.

Unique selling point/competitive advantage

When administered more than 4 hours after stroke in a rodent model, a single dose of the therapeutic demonstrates significant reduction in infarct size and improvement in motor coordination and neurological score.

Investment or collaboration opportunities

UniQuest, the commercialisation company of The University of Queensland, is seeking an investment or licensing partner.

Intellectual property rights

A patent has been filed.

Contact

Dr Stephen Earl
Director, Commercial Engagement - Health
Phone: +61 7 3346 2193
Email: s.earl@uniquest.com.au

More information

Visit Uniquest for more information.

Also consider...

• Read about other investment-ready opportunities.
• Discover other collaboration opportunities.